Does a Minimally Invasive Approach to Liver Resection Improve Postoperative Outcomes?

Completed

• Conditions: Hepatic Neoplasms

• Registration Number: NCT07169877
• Lead Sponsor: Icahn School of Medicine at Mount Sinai

Brief Summary

A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database to identify adult patients who underwent liver resection between 2022 and 2023. Primary outcomes included 30-day mortality, sepsis, septic shock, readmission, and reoperation.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-01
• Primary Completion: 2023-12-31
• Study Completion: 2023-12-31
• Status Verified: 2025-09
• Study First Submitted: 2025-09-05
• Study First Submitted QC: 2025-09-05
• Last Update Submitted: 2025-09-05
• Study First Posted: 2025-09-12
• Last Update Posted: 2025-09-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 9411

Inclusion Criteria

- Retrospective patients with condition only

Exclusion Criteria

- none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
30-day mortality	30 days	Number of deaths at 30 days
Number of participants with Sepsis	30 days	Number of participants with sepsis at 30 days
Number of participants with Septic Shock	30 days	Number of participants with septic shock at 30 days
Number of readmissions	30 days	Number of participants who had a remission at 30 days
Number of reoperations	30 days	Number of participants who had an reoperation at 30 days

Trial Locations

Locations (1)

Icahn School of Medicine at Mount Sinai; 🇺🇸 New York, New York, United States